AAAAAA
Results: 1-25/41
Authors:
CAIRNCROSS JG
UEKI K
ZLATESCU MC
LISLE DK
FINKELSTEIN DM
HAMMOND RR
SILVER JS
STARK PC
MACDONALD DR
INO Y
RAMSAY DA
LOUIS DN
Citation: Jg. Cairncross et al., SPECIFIC GENETIC PREDICTORS OF CHEMOTHERAPEUTIC RESPONSE AND SURVIVALIN PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMAS, Journal of the National Cancer Institute, 90(19), 1998, pp. 1473-1479
GENETIC BACKGROUND INFLUENCES TIMING, MORPHOLOGY AND DISSEMINATION OFLYMPHOMAS IN P53-DEFICIENT MICE
Authors:
VANMEYEL DJ
SANCHEZSWEATMAN OH
KERKVLIET N
STITT L
RAMSAY DA
KHOKHA R
CHAMBERS AF
CAIRNCROSS JG
Citation: Dj. Vanmeyel et al., GENETIC BACKGROUND INFLUENCES TIMING, MORPHOLOGY AND DISSEMINATION OFLYMPHOMAS IN P53-DEFICIENT MICE, International journal of oncology, 13(5), 1998, pp. 917-922
Authors:
PECH IV
PETERSON K
CAIRNCROSS JG
Citation: Iv. Pech et al., CHEMOTHERAPY FOR BRAIN-TUMORS, Oncology, 12(4), 1998, pp. 537
Authors:
DEANGELIS LM
CAIRNCROSS JG
Citation: Lm. Deangelis et Jg. Cairncross, THE SHAPIRO RANKIN-SHAPIRO ARTICLE REVIEWED, Oncology, 12(2), 1998, pp. 240
Authors:
CAIRNCROSS JG
Citation: Jg. Cairncross, COGNITION IN SURVIVORS OF HIGH-GRADE GLIOMA, Journal of clinical oncology, 16(9), 1998, pp. 3210-3211
Authors:
DEANGELIS LM
BURGER PC
GREEN SB
CAIRNCROSS JG
Citation: Lm. Deangelis et al., MALIGNANT GLIOMA - WHO BENEFITS FROM ADJUVANT CHEMOTHERAPY, Annals of neurology, 44(4), 1998, pp. 691-695
Authors:
SCOTT JN
REWCASTLE NB
BRASHER PMA
FULTON D
HAGEN NA
MACKINNON JA
SUTHERLAND G
CAIRNCROSS JG
FORSYTH P
Citation: Jn. Scott et al., LONG-TERM GLIOBLASTOMA-MULTIFORME SURVIVORS - A POPULATION-BASED STUDY, Canadian journal of neurological sciences, 25(3), 1998, pp. 197-201
Authors:
BAUMAN GS
FISHER BJ
CAIRNCROSS JG
MACDONALD D
Citation: Gs. Bauman et al., BIHEMISPHERIC MALIGNANT GLIOMA - ONE SIZE DOES NOT FIT ALL, Journal of neuro-oncology, 38(1), 1998, pp. 83-89
Authors:
PATEL A
VANMEYEL DJ
MOHAPATRA G
BOLLEN A
WRENSCH M
CAIRNCROSS JG
FEUERSTEIN BG
Citation: A. Patel et al., GLIOMAS IN FAMILIES - CHROMOSOMAL ANALYSIS BY COMPARATIVE GENOMIC HYBRIDIZATION, Cancer genetics and cytogenetics, 100(1), 1998, pp. 77-83
Authors:
MINTZ AP
CAIRNCROSS JG
Citation: Ap. Mintz et Jg. Cairncross, TREATMENT OF A SINGLE BRAIN METASTASIS - THE ROLE OF RADIATION FOLLOWING SURGICAL RESECTION, JAMA, the journal of the American Medical Association, 280(17), 1998, pp. 1527-1529
Authors:
FISHER BJ
BAUMAN GS
LEIGHTON CE
STITT L
CAIRNCROSS JG
MACDONALD DR
Citation: Bj. Fisher et al., LOW-GRADE GLIOMAS IN CHILDREN - TUMOR VOLUME RESPONSE TO RADIATION, Journal of neurosurgery, 88(6), 1998, pp. 969-974
Authors:
LOUIS DN
CAIRNCROSS JG
Citation: Dn. Louis et Jg. Cairncross, SPECIFIC CHROMOSOMAL LOSSES PREDICT CHEMOTHERAPEUTIC RESPONSE AND SURVIVAL IN PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMAS, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 14-14
Authors:
FORSYTH PAJ
PETROV E
MAHALLATI H
CAIRNCROSS JG
BRASHER P
MACRAE ME
HAGEN NA
BARNES P
SEVICK RJ
Citation: Paj. Forsyth et al., PROSPECTIVE-STUDY OF POSTOPERATIVE MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH MALIGNANT GLIOMAS, Journal of clinical oncology, 15(5), 1997, pp. 2076-2081
Authors:
MASON W
LOUIS DN
CAIRNCROSS JG
Citation: W. Mason et al., CHEMOSENSITIVE GLIOMAS IN ADULTS - WHICH ONES AND WHY, Journal of clinical oncology, 15(12), 1997, pp. 3423-3426
Authors:
SCOTT JN
REWCASTLE NB
BRASHER P
MACKINNON J
HAGEN N
FORSYTH P
CAIRNCROSS JG
FULTON D
Citation: Jn. Scott et al., LONG-TERM GLIOBLASTOMA-MULTIFORME SURVIVORS - A POPULATION-BASED STUDY IN ALBERTA FROM 1975 TO 1991, Annals of neurology, 42(3), 1997, pp. 279-279
Authors:
BAUMAN GS
CAIRNCROSS JG
Citation: Gs. Bauman et Jg. Cairncross, REGARDING, ALISON, SCHULSINGER, VONGTAMA, IJROBP-37-399-403-1997, International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 779-779
Authors:
IRISH WD
MACDONALD DR
CAIRNCROSS JG
Citation: Wd. Irish et al., MEASURING BIAS IN UNCONTROLLED BRAIN-TUMOR TRIALS - TO RANDOMIZE OR NOT TO RANDOMIZE, Canadian journal of neurological sciences, 24(4), 1997, pp. 307-312
Authors:
PERRY JR
DEANGELIS LM
SCHOLD SC
BURGER PC
BREM H
BROWN MT
CURRAN WJ
SCOTT CB
PRADOS MD
KAPLAN R
CAIRNCROSS JG
Citation: Jr. Perry et al., CHALLENGES IN THE DESIGN AND CONDUCT OF PHASE-III BRAIN-TUMOR THERAPYTRIALS, Neurology, 49(4), 1997, pp. 912-917
Authors:
FORSYTH PAJ
CAIRNCROSS JG
Citation: Paj. Forsyth et Jg. Cairncross, CHEMOTHERAPY FOR MALIGNANT GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 371-393
Authors:
PETERSON K
CAIRNCROSS JG
Citation: K. Peterson et Jg. Cairncross, OLIGODENDROGLIOMA, Cancer investigation, 14(3), 1996, pp. 243-251
Authors:
DEANGELIS LM
BURGER PC
GREEN SB
CAIRNCROSS JG
Citation: Lm. Deangelis et al., ADJUVANT CHEMOTHERAPY FOR MALIGNANT GLIOMAS - WHO BENEFITS, Annals of neurology, 40(3), 1996, pp. 12-12
Authors:
HALPERIN EC
HERNDON J
SCHOLD SC
BROWN M
VICK N
CAIRNCROSS JG
MACDONALD DR
GASPAR L
FISCHER B
DROPCHO E
ROSENFELD S
MOROWITZ R
PIEPMEIER J
HAIT W
BYRNE T
SALTER M
IMPERATO J
KHANDEKAR J
PALEOLOGOS N
BURGER P
BENTEL GC
FRIEDMAN A
Citation: Ec. Halperin et al., A PHASE-III RANDOMIZED PROSPECTIVE TRIAL OF EXTERNAL-BEAM RADIOTHERAPY, MITOMYCIN-C, CARMUSTINE, AND 6-MERCAPTOPURINE FOR THE TREATMENT OF ADULTS WITH ANAPLASTIC GLIOMA OF THE BRAIN, International journal of radiation oncology, biology, physics, 34(4), 1996, pp. 793-802
Authors:
SCOTT J
REWCASTLE NB
BRASHER P
MACKINNON J
HAGEN N
CAIRNCROSS JG
FORSYTH P
Citation: J. Scott et al., WHICH GBM PATIENT WILL BE A LONG-TERM SURVIVOR - A CASE-CONTROLLED, POPULATION-BASED STUDY IN SOUTHERN ALBERTA, Neurology, 46(2), 1996, pp. 2040-2040
Authors:
PETERSON K
PALEOLOGOS N
FORSYTH P
MACDONALD DR
CAIRNCROSS JG
Citation: K. Peterson et al., SALVAGE CHEMOTHERAPY FOR OLIGODENDROGLIOMA, Journal of neurosurgery, 85(4), 1996, pp. 597-601
Authors:
NUTT CL
CHAMBERS AF
CAIRNCROSS JG
Citation: Cl. Nutt et al., WILD-TYPE P53 RENDERS MOUSE ASTROCYTES RESISTANT TO 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA DESPITE THE ABSENCE OF A P53-DEPENDENT CELL-CYCLE ARREST, Cancer research, 56(12), 1996, pp. 2748-2751